3. Assay
• An assay is an investigative procedure for qualitatively
assessing or quantitatively measuring the presence or
amount or the functional activity of a target entity (the
analyte) which can be a drug or biochemical substance or
organic sample
4. Types of Assays
• Chemical assays
• Immunoassays
• Microbiological assays
• Bioassay
6. An immunoassay is a test that uses antibody and antigen
complexes as a means of generating measurable result
or
An immunoassay is an analytical method which uses
antibodies as reagents to quantitate or detect specific
analytes
10. Competitive Format
• In competitive formats, unlabelled analyte (usually antigen)
in the test sample is measured by its ability to compete
with labeled antigen in the immunoassay.
• The unlabeled antigen blocks the ability of the labeled
antigen to bind because that binding site on the antibody is
already occupied.
11. One step competitive
format
• Both the labeled antigen reagent (Ag*) and the unlabeled specimen
(or test sample analyte) compete for a limited amount of antibody.
12. Two step competitive
format• The antibody concentration of the reaction solution is present in
excess in comparison to the concentration of antigen
• Antibody reagent is first incubated with specimen containing
antigens of interest; then in the second step, labeled antigen is
added
• Improved assay sensitivity compared to one step assay formats
13.
14. Noncompetitive (Sandwich) Method
• “Sandwich” assay because analyte is bound (sandwiched)
between two highly specific antibody reagents
• Provides highest level of assay sensitivity and specificity
• Applied to the measurement of critical analytes such as cardiac
and hepatitis markers
15.
16. Homogen
eou
s
and
Het
ero
gen
eou
s
Im
mu
• Immunoassay methods that require separation of bound Ab-Ag*
complex are referred to as heterogeneous immunoassays. Those that
do not require separation are referred to as homogeneous
immunoassays.
• Homogeneous methods have been generally applied to the
measurement of small analytes such as abused and therapeutic drugs.
19. • Fluorescent compound in labeling the antibodies and antigen
• Europium fluoresces when it excite by light in the presence of a
developing solution
• It is 10 times more sensitive than RIA
FLUROIMMUNOASSAY
20. • A modern fluorescent based immunoassay uses as the
detection reagent a fluorescent compound which
absorbs light or energy (excitation energy) at a specific
wavelength and then emits light or energy at a different
wavelength
• The difference between the wavelength of the excitation
light and the emission light is called the Stokes shift.
21. Application
of
im
mu
noa
ssa
y
in
• Many of the macromolecule that can found in food are
good antigen and antibodies are capable of recognizing
them and small molecule.
• Composition of raw material and final product
• Harmful and useful minor substances with biological
activity (toxins and allergens)
• Enzyme detection
• Contaminants detection and determination (hormones
,drug, pesticides residue)
23. It is the production andemission of light by
alivingorganism.
Widespread acrossmarine zooplankton and
micro-nektonic life.
(BIOS - LIVING,LUMEN -LIGHT)
BIOLUMINISCENCE
24. Product of areaction
- Chemical (luciferin)
- Enzyme (luciferase).
Luciferin-indole derivative consisting of tryptamine,
arginine, and isoleusine.
MECHANISM
26. “One of the most important processes in the
ocean, and yet hardly anyone wasstudying it.”
Theseare absent in freshwater forms.
Thesemostly the characteristic feature of
midwater and bottom dwelling deep seafishes.
BIOLUMINISCENCE IN FISH
27. Fisheswith luminiscent organs are world wide
in distribution.
Majority ofthem are bathy pelagic living at a
medium depth(500-2000).
In fishes the luminescence is generally blueor
green.
28. 70%of all species
collected
from Bermuda and south
atlantic had light organs.
Systematic survey shows 10-
15%of all marine fish
genera contain luminous
organs.
29. New speciesof luminescent fish arediscovered
yearly
But the function and physiology of the lightorgans
remain more speculation than scientificfact.
Accessdifficulties, expensive ship and submarine
cost ,and low funding have hamstrung effect and
• our knowledge of bioluminescent fish lagsbehind.
CONCLUSION